Loading...

Pak Fah Yeow International

SEHK:239
Snowflake Description

Flawless balance sheet second-rate dividend payer.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
239
SEHK
HK$957M
Market Cap
  1. Home
  2. HK
  3. Pharmaceuticals & Biotech
Company description

Pak Fah Yeow International Limited, an investment holding company, manufactures, markets, and distributes healthcare products under the Hoe Hin brand name in the People’s Republic of China, Southeast Asia, North America, the United Kingdom, and internationally. The last earnings update was 149 days ago. More info.


Add to Portfolio Compare Print
239 Share Price and Events
7 Day Returns
2.3%
SEHK:239
4.3%
HK Pharmaceuticals
1.6%
HK Market
1 Year Returns
-8.1%
SEHK:239
-11%
HK Pharmaceuticals
-11%
HK Market
239 Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Pak Fah Yeow International (239) 2.3% 5.9% 2.3% -8.1% -21.1% 14.8%
HK Pharmaceuticals 4.3% 15% -4.9% -11% 55.6% 28.9%
HK Market 1.6% 6.7% 6.9% -11% 34.7% 15.6%
1 Year Return vs Industry and Market
  • 239 outperformed the Pharmaceuticals industry which returned -11% over the past year.
  • 239 outperformed the Market in Hong Kong which returned -11% over the past year.
Price Volatility
239
Industry
5yr Volatility vs Market

239 Value

 Is Pak Fah Yeow International undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Pak Fah Yeow International to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Pak Fah Yeow International.

SEHK:239 Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Extrapolated from most recent financials. See below
Discount Rate (Cost of Equity) See below 8.4%
Perpetual Growth Rate 10-Year HK Government Bond Rate 2%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for SEHK:239
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year HK Govt Bond Rate 2%
Equity Risk Premium S&P Global 8%
Pharmaceuticals Unlevered Beta Simply Wall St/ S&P Global 0.78
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.776 (1 + (1- 25%) (2.61%))
0.791
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
0.8
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 2% + (0.8 * 8%)
8.4%

Discounted Cash Flow Calculation for SEHK:239 using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Pak Fah Yeow International is arrived at by discounting future cash flows to their present value using the 2 stage method. We use analyst's estimates of cash flows going forward 5 years for the 1st stage, the 2nd stage assumes the company grows at a stable rate into perpetuity.

SEHK:239 DCF 1st Stage: Next 5 year cash flow forecast
2019 2020 2021 2022 2023
Levered FCF (HKD, Millions) 63.65 64.74 65.85 66.97 68.12
Source Est @ 1.71% Est @ 1.71% Est @ 1.71% Est @ 1.71% Est @ 1.71%
Present Value
Discounted (@ 8.4%)
58.72 55.10 51.70 48.50 45.51
Present value of next 5 years cash flows HK$259.53
SEHK:239 DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2023 × (1 + g) ÷ (Discount Rate – g)
= HK$68.12 × (1 + 2%) ÷ (8.4% – 2%)
HK$1,086.10
Present Value of Terminal Value = Terminal Value ÷ (1 + r)5
= HK$1,086.10 ÷ (1 + 8.4%)5
HK$725.62
SEHK:239 Total Equity Value
Calculation Result
Total Equity Value = Present value of next 5 years cash flows + Terminal Value
= HK$259.53 + HK$725.62
HK$985.15
Equity Value per Share
(HKD)
= Total value / Shares Outstanding
= HK$985.15 / 311.64
HK$3.16
SEHK:239 Discount to Share Price
Calculation Result
Value per share (HKD) From above. HK$3.16
Current discount Discount to share price of HK$3.07
= -1 x (HK$3.07 - HK$3.16) / HK$3.16
2.9%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price Pak Fah Yeow International is available for.
Intrinsic value
3%
Share price is HK$3.07 vs Future cash flow value of HK$3.16
Current Discount Checks
For Pak Fah Yeow International to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • Pak Fah Yeow International's share price is below the future cash flow value, but not at a moderate discount (< 20%).
  • Pak Fah Yeow International's share price is below the future cash flow value, but not at a substantial discount (< 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Pak Fah Yeow International's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Pak Fah Yeow International's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
SEHK:239 PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-06-30) in HKD HK$0.21
SEHK:239 Share Price ** SEHK (2019-02-15) in HKD HK$3.07
Hong Kong Pharmaceuticals Industry PE Ratio Median Figure of 30 Publicly-Listed Pharmaceuticals Companies 14.33x
Hong Kong Market PE Ratio Median Figure of 1,482 Publicly-Listed Companies 10.71x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Pak Fah Yeow International.

SEHK:239 PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= SEHK:239 Share Price ÷ EPS (both in HKD)

= 3.07 ÷ 0.21

14.42x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Pak Fah Yeow International is overvalued based on earnings compared to the HK Pharmaceuticals industry average.
  • Pak Fah Yeow International is overvalued based on earnings compared to the Hong Kong market.
Price based on expected Growth
Does Pak Fah Yeow International's expected growth come at a high price?
Raw Data
SEHK:239 PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 14.42x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
10.1%per year
Hong Kong Pharmaceuticals Industry PEG Ratio Median Figure of 16 Publicly-Listed Pharmaceuticals Companies 1.12x
Hong Kong Market PEG Ratio Median Figure of 465 Publicly-Listed Companies 0.76x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Pak Fah Yeow International, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Pak Fah Yeow International's assets?
Raw Data
SEHK:239 PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-06-30) in HKD HK$2.39
SEHK:239 Share Price * SEHK (2019-02-15) in HKD HK$3.07
Hong Kong Pharmaceuticals Industry PB Ratio Median Figure of 34 Publicly-Listed Pharmaceuticals Companies 1.44x
Hong Kong Market PB Ratio Median Figure of 2,117 Publicly-Listed Companies 0.97x
SEHK:239 PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= SEHK:239 Share Price ÷ Book Value per Share (both in HKD)

= 3.07 ÷ 2.39

1.28x

* Primary Listing of Pak Fah Yeow International.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Pak Fah Yeow International is good value based on assets compared to the HK Pharmaceuticals industry average.
X
Value checks
We assess Pak Fah Yeow International's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Pharmaceuticals industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Pharmaceuticals industry average (and greater than 0)? (1 check)
  5. Pak Fah Yeow International has a total score of 1/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

239 Future Performance

 How is Pak Fah Yeow International expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

  • No analysts cover Pak Fah Yeow International, future earnings growth has been estimated based on fundamentals.
The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
10.1%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Pak Fah Yeow International expected to grow at an attractive rate?
  • Pak Fah Yeow International's earnings growth is expected to exceed the low risk savings rate of 2%.
Growth vs Market Checks
  • Pak Fah Yeow International's earnings growth is positive but not above the Hong Kong market average.
  • Unable to compare Pak Fah Yeow International's revenue growth to the Hong Kong market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
SEHK:239 Future Growth Rates Data Sources
Data Point Source Value (per year)
SEHK:239 Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts 10.1%
Hong Kong Pharmaceuticals Industry Earnings Growth Rate Market Cap Weighted Average 14.1%
Hong Kong Pharmaceuticals Industry Revenue Growth Rate Market Cap Weighted Average 15.1%
Hong Kong Market Earnings Growth Rate Market Cap Weighted Average 11.7%
Hong Kong Market Revenue Growth Rate Market Cap Weighted Average 10%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
SEHK:239 Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (7 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in HKD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
SEHK:239 Past Financials Data
Date (Data in HKD Millions) Revenue Cash Flow Net Income *
2018-06-30 146 63 66
2018-03-31 163 81 84
2017-12-31 180 99 103
2017-09-30 183 85 104
2017-06-30 186 72 106
2017-03-31 185 69 84
2016-12-31 183 65 61
2016-09-30 176 67 48
2016-06-30 170 69 34
2016-03-31 176 71 48
2015-12-31 183 72 61
2015-09-30 189 72 91

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Pak Fah Yeow International's earnings are expected to grow by 10.1% yearly, however this is not considered high growth (20% yearly).
  • Unable to determine if Pak Fah Yeow International is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
SEHK:239 Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (7 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from Pak Fah Yeow International Company Filings, last reported 7 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

SEHK:239 Past Financials Data
Date (Data in HKD Millions) EPS *
2018-06-30 0.21
2018-03-31 0.27
2017-12-31 0.33
2017-09-30 0.33
2017-06-30 0.34
2017-03-31 0.27
2016-12-31 0.20
2016-09-30 0.15
2016-06-30 0.11
2016-03-31 0.15
2015-12-31 0.20
2015-09-30 0.29

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Pak Fah Yeow International will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
X
Future performance checks
We assess Pak Fah Yeow International's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Hong Kong market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Hong Kong market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Pak Fah Yeow International has a total score of 1/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

239 Past Performance

  How has Pak Fah Yeow International performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Pak Fah Yeow International's growth in the last year to its industry (Pharmaceuticals).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Pak Fah Yeow International's year on year earnings growth rate was negative over the past 5 years and the most recent earnings are below average.
  • Pak Fah Yeow International's 1-year earnings growth is negative, it can't be compared to the 5-year average.
  • Pak Fah Yeow International's 1-year earnings growth is negative, it can't be compared to the HK Pharmaceuticals industry average.
Earnings and Revenue History
Pak Fah Yeow International's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Pak Fah Yeow International Company Filings, last reported 7 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

SEHK:239 Past Revenue, Cash Flow and Net Income Data
Date (Data in HKD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-06-30 146.43 66.34 32.05
2018-03-31 163.09 84.46 32.94
2017-12-31 179.74 102.59 33.84
2017-09-30 183.04 104.38 32.96
2017-06-30 186.34 106.18 32.09
2017-03-31 184.75 83.69 31.37
2016-12-31 183.16 61.20 30.65
2016-09-30 176.47 47.70 31.20
2016-06-30 169.78 34.20 31.75
2016-03-31 176.18 47.61 32.12
2015-12-31 182.57 61.01 32.48
2015-09-30 188.88 91.50 33.86
2015-06-30 195.20 121.98 35.23
2015-03-31 191.33 134.22 34.08
2014-12-31 187.45 146.47 32.93
2014-09-30 175.76 121.12 31.37
2014-06-30 164.07 95.78 29.80
2014-03-31 163.04 83.33 29.01
2013-12-31 162.02 70.88 28.22
2013-09-30 148.83 68.31 26.69
2013-06-30 135.65 65.74 25.16
2013-03-31 132.56 65.04 24.89
2012-12-31 129.46 64.34 24.61
2012-09-30 129.87 55.97 24.67
2012-06-30 130.28 47.59 24.73
2012-03-31 123.51 46.91 24.23

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Pak Fah Yeow International has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • Pak Fah Yeow International used its assets more efficiently than the HK Pharmaceuticals industry average last year based on Return on Assets.
  • Pak Fah Yeow International's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess Pak Fah Yeow International's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Pharmaceuticals industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Pak Fah Yeow International has a total score of 1/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

239 Health

 How is Pak Fah Yeow International's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Pak Fah Yeow International's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Pak Fah Yeow International is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Pak Fah Yeow International's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Pak Fah Yeow International's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is covered by short term assets, assets are 7.3x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Pak Fah Yeow International Company Filings, last reported 7 months ago.

SEHK:239 Past Debt and Equity Data
Date (Data in HKD Millions) Total Equity Total Debt Cash & Short Term Investments
2018-06-30 745.66 24.94 148.24
2018-03-31 745.66 24.94 148.24
2017-12-31 748.51 26.66 141.83
2017-09-30 748.51 26.66 141.83
2017-06-30 694.11 27.73 120.55
2017-03-31 694.11 27.73 120.55
2016-12-31 633.51 27.46 89.34
2016-09-30 633.51 27.46 89.34
2016-06-30 589.43 30.36 51.67
2016-03-31 589.43 30.36 51.67
2015-12-31 624.39 35.14 19.86
2015-09-30 624.39 35.14 19.86
2015-06-30 615.72 37.82 47.86
2015-03-31 615.72 37.82 47.86
2014-12-31 622.63 43.76 14.96
2014-09-30 622.63 43.76 14.96
2014-06-30 548.21 53.42 39.66
2014-03-31 548.21 53.42 39.66
2013-12-31 516.86 49.95 16.17
2013-09-30 516.86 49.95 16.17
2013-06-30 486.05 49.47 23.70
2013-03-31 486.05 49.47 23.70
2012-12-31 477.44 56.00 25.41
2012-09-30 477.44 56.00 25.41
2012-06-30 414.80 56.90 28.69
2012-03-31 414.80 56.90 28.69
  • Pak Fah Yeow International's level of debt (3.3%) compared to net worth is satisfactory (less than 40%).
  • The level of debt compared to net worth has been reduced over the past 5 years (10.2% vs 3.3% today).
  • Debt is well covered by operating cash flow (253.6%, greater than 20% of total debt).
  • Interest payments on debt are well covered by earnings (EBIT is 55.1x coverage).
X
Financial health checks
We assess Pak Fah Yeow International's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Pak Fah Yeow International has a total score of 6/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

239 Dividends

 What is Pak Fah Yeow International's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
4.12%
Current annual income from Pak Fah Yeow International dividends.
If you bought HK$2,000 of Pak Fah Yeow International shares you are expected to receive HK$82 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Pak Fah Yeow International's pays a higher dividend yield than the bottom 25% of dividend payers in Hong Kong (2%).
  • Pak Fah Yeow International's dividend is below the markets top 25% of dividend payers in Hong Kong (5.51%).
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
SEHK:239 Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
Hong Kong Pharmaceuticals Industry Average Dividend Yield Market Cap Weighted Average of 24 Stocks 1.5%
Hong Kong Market Average Dividend Yield Market Cap Weighted Average of 916 Stocks 3.5%
Hong Kong Minimum Threshold Dividend Yield 10th Percentile 1.1%
Hong Kong Bottom 25% Dividend Yield 25th Percentile 2%
Hong Kong Top 25% Dividend Yield 75th Percentile 5.5%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

SEHK:239 Past Annualized Dividends Data
Date (Data in HK$) Dividend per share (annual) Avg. Yield (%)
2018-04-19 0.127 3.965
2017-04-18 0.125 3.645
2017-03-27 0.125 3.534
2016-04-15 0.125 3.370
2016-03-30 0.125 3.237
2015-12-15 0.202 4.976
2015-09-11 0.206 5.181
2015-08-26 0.206 5.556
2015-04-16 0.179 4.355
2015-03-26 0.179 4.875
2014-08-25 0.158 4.855
2014-06-25 0.155 4.728
2014-04-16 0.154 5.247
2014-03-27 0.154 5.563
2013-04-17 0.109 4.252
2013-03-27 0.109 4.801
2012-08-31 0.108 5.085
2012-06-28 0.103 5.137
2012-03-27 0.108 5.401
2011-12-22 0.063 3.025
2011-06-28 0.077 3.624
2011-03-23 0.128 5.287
2010-04-29 0.107 5.023
2010-04-22 0.107 5.841
2009-09-21 0.060 4.498
2009-04-22 0.100 9.606
2009-02-16 0.043 6.299

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
  • Dividends per share have increased over the past 10 years.
Current Payout to shareholders
What portion of Pak Fah Yeow International's earnings are paid to the shareholders as a dividend.
  • Dividends paid are covered by earnings (1.8x coverage).
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Pak Fah Yeow International's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.1%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Pak Fah Yeow International afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Pak Fah Yeow International has a total score of 3/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

239 Management

 What is the CEO of Pak Fah Yeow International's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Wee Gan
COMPENSATION HK$6,988,000
AGE 71
TENURE AS CEO 7.4 years
CEO Bio

Mr. Wee Sean Gan has been the Chief Executive Officer of Pak Fah Yeow International Ltd. since September 1, 2011 and serves as its Executive Chairman. Mr. Gan also serves as an Island Command Vice President of the St. John's Ambulance Brigade in Hong Kong. He has been actively involved in the management of Pak Fah Yeow since 1971. He served as Acting Chief Executive Officer of Pak Fah Yeow International Ltd., from April 21, 2008 to September 1, 2011. Mr. Gan has been an Executive Director of Pak Fah Yeow International Ltd. since October 8, 1991. He was the Chairman and Vice Chairman of Chung Sing Benevolent Society from 1987 to 1990 and from 1981 to 1986, respectively. He was the Chairman of the Malaysian Association in Hong Kong from 1987 to 1989 and was a Founder Member of the Institute of Marketing in Hong Kong. Mr. Gan is a Fellow of the Institute of Chartered Secretaries and Administrators and the Chartered Institute of Marketing.

CEO Compensation
  • Wee's compensation has been consistent with company performance over the past year.
  • Wee's remuneration is higher than average for companies of similar size in Hong Kong.
Management Team

Wee Gan

TITLE
Executive Chairman & CEO
COMPENSATION
HK$7M
AGE
71
TENURE
7.4 yrs

Stephen Gan

TITLE
Executive Director
COMPENSATION
HK$5M
AGE
56

Gavin Gan

TITLE
Executive Director
COMPENSATION
HK$975K
AGE
37

Gan Eng

TITLE

Hung Kei Tsang

TITLE
Chief Financial Officer
AGE
47

Tai On Lo

TITLE
Company Secretary
AGE
64
TENURE
10.1 yrs

Lai Ching Yau

TITLE
COO & Executive Director of Hoe Hin Pak Fah Yeow Manufactory Ltd
AGE
53

Anthony Tang

TITLE
Head of Sales & Marketing of Hoe Hin Pak Fah Yeow Manufactory Limited
AGE
56
Board of Directors Tenure

Average tenure and age of the Pak Fah Yeow International board of directors in years:

12.6
Average Tenure
55.5
Average Age
  • The average tenure for the Pak Fah Yeow International board of directors is over 10 years, this suggests they are a seasoned and experienced board.
Board of Directors

Wee Gan

TITLE
Executive Chairman & CEO
COMPENSATION
HK$7M
AGE
71

Stephen Gan

TITLE
Executive Director
COMPENSATION
HK$5M
AGE
56

Gavin Gan

TITLE
Executive Director
COMPENSATION
HK$975K
AGE
37
TENURE
3.4 yrs

Lai Ching Yau

TITLE
COO & Executive Director of Hoe Hin Pak Fah Yeow Manufactory Ltd
AGE
53

Lawrence Leung

TITLE
Independent Non-Executive Director
COMPENSATION
HK$124K
AGE
70
TENURE
12.6 yrs

Ada Wong

TITLE
Independent Non Executive Director
COMPENSATION
HK$124K
AGE
58
TENURE
14.4 yrs

Arnold Ip

TITLE
Independent Non Executive Director
COMPENSATION
HK$124K
AGE
55
TENURE
14.4 yrs

Anita Gan

TITLE
Non-Executive Director
COMPENSATION
HK$124K
AGE
50
TENURE
3.4 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (HK$) Value (HK$)
X
Management checks
We assess Pak Fah Yeow International's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Pak Fah Yeow International has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

239 News

Simply Wall St News

How Much is Pak Fah Yeow International Limited's (HKG:239) CEO Getting Paid?

Wee Gan became the CEO of Pak Fah Yeow International Limited (HKG:239) in 2011. … This report will, first, examine the CEO compensation levels in comparison to CEO compensation at companies of similar size. … How Does Wee Gan's Compensation Compare With Similar Sized Companies?

Simply Wall St -

What Kind Of Shareholder Owns Most Pak Fah Yeow International Limited (HKG:239) Stock?

Every investor in Pak Fah Yeow International Limited (HKG:239) should be aware of the most powerful shareholder groups. … Pak Fah Yeow International is not a large company by global standards. … See our latest analysis for Pak Fah Yeow International

Simply Wall St -

Is Pak Fah Yeow International Limited (HKG:239) An Attractive Dividend Stock?

Historically, Pak Fah Yeow International Limited (HKG:239) has paid dividends to shareholders, and these days it yields 4.3%. … Does Pak Fah Yeow International tick all the boxes of a great dividend stock? … Check out our latest analysis for Pak Fah Yeow International

Simply Wall St -

A Closer Look At Pak Fah Yeow International Limited's (HKG:239) Uninspiring ROE

While some investors are already well versed in financial metrics (hat tip), this article is for those who would like to learn about Return On Equity (ROE) and why it is important. … Our data shows Pak Fah Yeow International has a return on equity of 8.9% for the last year. … Return on Equity = Net Profit ÷ Shareholders' Equity

Simply Wall St -

Do You Like Pak Fah Yeow International Limited (HKG:239) At This P/E Ratio?

This article is written for those who want to get better at using price to earnings ratios (P/E ratios). … We'll look at Pak Fah Yeow International Limited's (HKG:239) P/E ratio and reflect on what it tells us about the company's share price. … Pak Fah Yeow International has a price to earnings ratio of 14.52, based on the last twelve months.

Simply Wall St -

Does Pak Fah Yeow International Limited's (HKG:239) CEO Pay Compare Well With Peers?

First, this article will compare CEO compensation with compensation at similar sized companies. … How Does Wee Gan's Compensation Compare With Similar Sized Companies. … According to our data, Pak Fah Yeow International Limited has a market capitalization of HK$938m, and pays its CEO total annual compensation worth HK$7m.

Simply Wall St -

Should You Buy Pak Fah Yeow International Limited (HKG:239) For Its Dividend?

A large part of investment returns can be generated by dividend-paying stock given their role in compounding returns over time. … Historically, Pak Fah Yeow International Limited (HKG:239) has paid dividends to shareholders, and these days it yields 4.0%. … Let's dig deeper into whether Pak Fah Yeow International should have a place in your portfolio.

Simply Wall St -

Interested In Pak Fah Yeow International Limited (HKG:239)’s Upcoming HK$0.078 Dividend? You Have 2 Days Left

Important news for shareholders and potential investors in Pak Fah Yeow International Limited (HKG:239): The dividend payment of HK$0.078 per share will be distributed into shareholder on 17 August 2018, and the stock will begin trading ex-dividend at an earlier date, 09 July 2018. … Investors looking for higher income-generating stocks to add to their portfolio should keep reading, as I take a deeper dive into Pak Fah Yeow International's latest financial data to analyse its dividend attributes. … When assessing a stock as a potential addition to my dividend Portfolio, I look at these five areas:

Simply Wall St -

Should Pak Fah Yeow International Limited (HKG:239) Be Your Next Stock Pick?

As an investor, I look for investments which does not compromise one fundamental factor for another. … By this I mean, I look at stocks holistically, from their financial health to their future outlook. … is a company with great financial health as well as a.

Simply Wall St -

Is Pak Fah Yeow International Limited (HKG:239) A Financially Sound Company?

How does 239’s operating cash flow stack up against its debt? … Moreover, 239 has produced cash from operations of HK$65.42M over the same time period, resulting in an operating cash to total debt ratio of 238.22%, meaning that 239’s debt is appropriately covered by operating cash. … In 239's, case, the ratio of 100x suggests that interest is comfortably covered, which means that lenders may be inclined to lend more money to the company, as it is seen as safe in terms of payback.Next Steps: 239’s high cash coverage and low debt levels indicate its ability to utilise its borrowings efficiently in order to generate ample cash flow.

Simply Wall St -

239 Company Info

Map
Description

Pak Fah Yeow International Limited, an investment holding company, manufactures, markets, and distributes healthcare products under the Hoe Hin brand name in the People’s Republic of China, Southeast Asia, North America, the United Kingdom, and internationally. It operates through three segments: Healthcare, Property Investments, and Treasury Investments. The company offers Hoe Hin White Flower Embrocation or Hoe Hin Pak Fah Yeow, a medicated oil; Hoe Hin Strain Relief; and Hoe Hin White Flower ointment products, as well as Fúzai 239, a floral-scented White Flower Embrocation. It also provides advertising agency services. Pak Fah Yeow International Limited is headquartered in Wan Chai, Hong Kong.

Details
Name: Pak Fah Yeow International Limited
239
Exchange: SEHK
Founded:
HK$956,734,800
311,640,000
Website: http://www.whiteflower.com
Address: Pak Fah Yeow International Limited
200 Gloucester Road,
11th Floor,
Wan Chai,
Hong Kong
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
SEHK 239 Ordinary Shares The Stock Exchange of Hong Kong Ltd. HK HKD 15. Sep 1992
Number of employees
Current staff
Staff numbers
96
Pak Fah Yeow International employees.
Industry
Pharmaceuticals
Pharmaceuticals & Biotech
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/02/15 12:46
End of day share price update: 2019/02/15 00:00
Last earnings filing: 2018/09/19
Last earnings reported: 2018/06/30
Last annual earnings reported: 2017/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.